Search | Paxxis: Ecossistema de Inovação Conectada

Zenovel Pharma ein Foto hinzugefügt Saúde & Bem Estar
2026-09-23 17:46:35 -

Key Highlights of the NDCT Amendment Rules 2026: Transforming India’s Clinical Research Landscape
The clinical research and pharmaceutical sectors in India are undergoing a profound evolution. To streamline drug development, eliminate procedural bottlenecks, and align national standards with global frameworks, the Ministry of Health and Family Welfare (MoHFW) and the Central Drugs Standard Control Organization (CDSCO) introduced the landmark New Drugs and Clinical Trials (NDCT) Amendment...

0 Kommentare 0 Anteile 0 Vorschau

Please log in to like, share and comment!
Zenovel Pharma ein Foto hinzugefügt Saúde & Bem Estar
2026-09-20 21:14:42 -

Mastering PK-Stat Reviews in Bioequivalence Studies
In the rigorous world of pharmaceutical development, proving that a generic or alternative formulation matches a brand-name reference product requires far more than just laboratory similarity. It demands undeniable mathematical and statistical proof. At the heart of this process lies the Pharmacokinetic-Statistical (PK-Stat) Review—the critical link that translates raw plasma...

0 Kommentare 0 Anteile 0 Vorschau

Please log in to like, share and comment!
Zenovel Pharma ein Foto hinzugefügt Saúde & Bem Estar
2026-09-22 17:19:58 -

Mastering Sponsor Oversight in Clinical Trials: Ensuring Quality and Compliance
In modern clinical research, outsourcing operational tasks to Contract Research Organizations (CROs), vendors, and central laboratories is standard practice. However, there is one critical responsibility that a pharmaceutical or biotech sponsor can never outsource: sponsor oversight. Regulatory authorities worldwide—including the US FDA, EMA, and CDSCO—make it explicitly clear that...

0 Kommentare 0 Anteile 0 Vorschau

Please log in to like, share and comment!